A structural equation modelling approach to explore the determinants of quality of life in schizophrenia

Schizophrenia Research

Volumn 171, Issue 1-3, 2016, Pages 27-34

  Alessandrini, Marine ^a   Lançon, Christophe ^a,b   Fond, Guillaume ^c,d   Faget Agius, Catherine ^a,b   Richieri, Raphaelle ^a,b   Faugere, Melanie ^a,b   Metairie, Emeline ^b   Boucekine, Mohamed ^a   Llorca, Pierre Michel ^c,e,f   Auquier, Pascal ^a   Boyer, Laurent ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

^b La Conception University Hospital ^*  (France)

^c FONDATION FONDAMENTAL   (France)

^d INSERM U955   (France)

^e UNIVERSITÉ CLERMONT AUVERGNE   (France)

^f UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

Author keywords

Depression; Functioning; Neurocognition; Psychotic symptoms; Quality of life; Schizophrenia; Structural equation modelling

Indexed keywords

ADULT; ARTICLE; CALGARY DEPRESSION SCALE; COGNITION; COGNITIVE DEFECT; COPING BEHAVIOR; CROSS-SECTIONAL STUDY; DEPRESSION; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT AUTONOMY; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; QUALITY OF LIFE; SCHIZOPHRENIA; SELF ESTEEM; STRUCTURAL EQUATION MODELING; ATTENTION; COGNITION DISORDERS; COHORT ANALYSIS; COMPLICATION; EXECUTIVE FUNCTION; MEMORY; MIDDLE AGED; MOOD DISORDERS; NEUROPSYCHOLOGICAL TEST; PHYSIOLOGY; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; STATISTICS; THEORETICAL MODEL; YOUNG ADULT;

ADULT; ATTENTION; COGNITION DISORDERS; COHORT STUDIES; CROSS-SECTIONAL STUDIES; EXECUTIVE FUNCTION; FEMALE; HUMANS; MALE; MEMORY; MIDDLE AGED; MODELS, THEORETICAL; MOOD DISORDERS; NEUROPSYCHOLOGICAL TESTS; PSYCHIATRIC STATUS RATING SCALES; QUALITY OF LIFE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; STATISTICS AS TOPIC; YOUNG ADULT;

EID: 84958110985     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2016.01.012     Document Type: Article

References (71)

1. Addington D., Addington J., Schissel B. A depression rating scale for schizophrenics. Schizophr. Res. 1990, 3:247-251. 10.1016/0920-9964(90)90005-R.
2. Addington D., Addington J., Maticka-Tyndale E. Assessing depression in schizophrenia: the Calgary Depression Scale. Br. J. Psychiatry 1993, 163:39-44.
3. Addington D.D., Azorin J.M., Falloon I.R.H., Gerlach J., Hirsch S.R., Siris S.G. Clinical issues related to depression in schizophrenia: an international survey of psychiatrists. Acta Psychiatr. Scand. 2002, 105:189-195.
4. Aki H., Tomotake M., Kaneda Y., Iga J., Kinouchi S., Shibuya-Tayoshi S., Tayoshi S.-Y., Motoki I., Moriguchi K., Sumitani S., Yamauchi K., Taniguchi T., Ishimoto Y., Ueno S., Ohmori T. Subjective and objective quality of life, levels of life skills, and their clinical determinants in outpatients with schizophrenia. Psychiatry Res. 2008, 158:19-25. 10.1016/j.psychres.2006.05.017.
5. American Psychiatric Association Diagnostic and Statistical Manual-Text Revision (DSM-IV-TRim, 2000) 2000, American Psychiatric Association.
6. Auquier P., Simeoni M., Sapin C., Reine G., Aghababian V., Cramer J., Lançon C. Development and validation of a patient-based health-related quality of life questionnaire in schizophrenia: the S-QoL. Schizophr. Res. 2003, 63:137-149. 10.1016/S0920-9964(02)00355-9.
7. Awad, Voruganti Measuring quality of life in patients with schizophrenia: an update. PharmacoEconomics 2012, 30:183-195. 10.2165/11594470-000000000-00000.
8. Baumstarck K., Boyer L., Boucekine M., Aghababian V., Parola N., Lançon C., Auquier P. Self-reported quality of life measure is reliable and valid in adult patients suffering from schizophrenia with executive impairment. Schizophr. Res. 2013, 147:58-67. 10.1016/j.schres.2013.03.008.
9. Bland J.M., Altman D.G. Multiple significance tests: the Bonferroni method. BMJ 1995, 310:170. 10.1136/bmj.310.6973.170.
10. Blum L.H., Vakhrusheva J., Saperstein A., Khan S., Chang R.W., Hansen M.C., Zemon V., Kimhy D. Depressed mood in individuals with schizophrenia: a comparison of retrospective and real-time measures. Psychiatry Res. 2015, 227:318-323. 10.1016/j.psychres.2015.03.008.
11. Bowie C.R., Twamley E.W., Anderson H., Halpern B., Patterson T.L., Harvey P.D. Self-assessment of functional status in schizophrenia. J. Psychiatr. Res. 2007, 41:1012-1018. 10.1016/j.jpsychires.2006.08.003.
12. Boyer L., Simeoni M.-C., Loundou A., D'Amato T., Reine G., Lancon C., Auquier P. The development of the S-QoL 18: a shortened quality of life questionnaire for patients with schizophrenia. Schizophr. Res. 2010, 121:241-250. 10.1016/j.schres.2010.05.019.
13. Boyer L., Aghababian V., Richieri R., Loundou A., Padovani R., Simeoni M.C., Auquier P., Lançon C. Insight into illness, neurocognition and quality of life in schizophrenia. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 2012, 36:271-276. 10.1016/j.pnpbp.2011.10.008.
14. Boyer L., Cermolacce M., Dassa D., Fernandez J., Boucekine M., Richieri R., Vaillant F., Dumas R., Auquier P., Lancon C. Neurocognition, insight and medication nonadherence in schizophrenia: a structural equation modeling approach. PLoS One 2012, 7. 10.1371/journal.pone.0047655.
15. Boyer L., Richieri R., Faget C., Padovani R., Vaillant F., Mundler O., Lançon C., Auquier P., Guedj E. Functional involvement of superior temporal sulcus in quality of life of patients with schizophrenia. Psychiatry Res. Neuroimaging 2012, 202:155-160. 10.1016/j.pscychresns.2012.02.006.
16. Boyer L., Baumstarck K., Boucekine M., Blanc J., Lançon C., Auquier P. Measuring quality of life in patients with schizophrenia: an overview. Expert Rev. Pharmacoecon. Outcomes Res. 2013, 13:343-349. 10.1586/erp.13.15.
17. Boyer L., Lancon C., Baumstarck K., Parola N., Berbis J., Auquier P. Evaluating the impact of a quality of life assessment with feedback to clinicians in patients with schizophrenia: randomised controlled trial. Br. J. Psychiatry 2013, 202:447-453. 10.1192/bjp.bp.112.123463.
18. Boyer L., Millier A., Perthame E., Aballea S., Auquier P., Toumi M. Quality of life is predictive of relapse in schizophrenia. BMC Psychiatry 2013, 13. 10.1186/1471-244X-13-15.
19. Boyer L., Baumstarck K., Guedj E., Auquier P. What's wrong with quality-of-life measures? A philosophical reflection and insights from neuroimaging. Expert Rev. Pharmacoecon. Outcomes Res. 2014, 14:767-769. 10.1586/14737167.2014.950236.
20. Boyer L., Testart J., Michel P., Richieri R., Faget-Agius C., Vanoye V., Auquier P., Lancon C., Guedj E. Neurophysiological correlates of metabolic syndrome and cognitive impairment in schizophrenia: a structural equation modeling approach. Psychoneuroendocrinology 2014, 50:95-105. 10.1016/j.psyneuen.2014.07.019.
21. Buchanan R.W., Kreyenbuhl J., Kelly D.L., Noel J.M., Boggs D.L., Fischer B.A., Himelhoch S., Fang B., Peterson E., Aquino P.R., Keller W. The 2009 Schizophrenia PORT psychopharmacological treatment recommendations and summary statements. Schizophr. Bull. 2010, 36:71-93. 10.1093/schbul/sbp116.
22. Buckley P.F., Miller B.J., Lehrer D.S., Castle D.J. Psychiatric comorbidities and schizophrenia. Schizophr. Bull. 2009, 35:383-402. 10.1093/schbul/sbn135.
23. Caqueo-Urízar A., Boyer L., Baumstarck K., Gilman S.E. Subjective perceptions of cognitive deficits and their influences on quality of life among patients with schizophrenia. Qual. Life Res. 2015, 10.1007/s11136-015-1019-2.
24. Chou C.-Y., Ma M.-C., Yang T.-T. Determinants of subjective health-related quality of life (HRQoL) for patients with schizophrenia. Schizophr. Res. 2014, 154:83-88. 10.1016/j.schres.2014.02.011.
25. Cohen J. Statistical Power Analysis for Behavioural Sciences 1982, Lawrence Erlbaum Associates, Hillsdale, NJ.
26. Cramer J.A., Rosenheck R., Xu W., Thomas J., Henderson W., Charney D.S. Quality of life in schizophrenia: a comparison of instruments. Schizophr. Bull. 2000, 26.
27. Dickerson F., Boronow J.J., Ringel N., Parente F. Social functioning and neurocognitive deficits in outpatients with schizophrenia: a 2-year follow-up. Schizophr. Res. 1999, 37:13-20.
28. Dumas R., Richieri R., Guedj E., Auquier P., Lancon C., Boyer L. Improvement of health-related quality of life in depression after transcranial magnetic stimulation in a naturalistic trial is associated with decreased perfusion in precuneus. Health Qual. Life Outcomes 2012, 10:87.
29. Eack S.M., Newhill C.E. Psychiatric symptoms and quality of life in schizophrenia: a meta-analysis. Schizophr. Bull. 2007, 33:1225-1237. 10.1093/schbul/sbl071.
30. Elis O., Caponigro J.M., Kring A.M. Psychosocial treatments for negative symptoms in schizophrenia: current practices and future directions. Clin. Psychol. Rev. 2013, 33:914-928. 10.1016/j.cpr.2013.07.001.
31. Englisch S., Inta D., Eer A., Zink M. Bupropion for depression in schizophrenia. Clin. Neuropharmacol. 2010, 33.
32. Faget-Agius C., Boyer L., Wirsich J., Ranjeva J.P., Richieri R., Soulier E., Confort-Gouny S., Auquier P., Guye M., Lançon C. Neural Substrate of Quality of Life in Patients with Schizophrenia: A Magnetisation Transfer Imaging Study 2015, Sci. Rep.
33. Falissard B. Modèles structuraux (structural models). Comprendre et Utiliser les Statistiques Dans les Sciences de la vie (Understanding and Using Statistics in Life-Related Sciences) 2005, Masson, Paris. B. Falissard (Ed.).
34. Fervaha G., Agid O., Takeuchi H., Foussias G., Remington G. Clinical determinants of life satisfaction in chronic schizophrenia: data from the CATIE study. Schizophr. Res. 2013, 151:203-208. 10.1016/j.schres.2013.10.021.
35. Fervaha G., Takeuchi H., Agid O., Lee J., Foussias G., Remington G. Determinants of patient-rated and clinician-rated illness severity in schizophrenia. J Clin Psychiatry 2015, 76:924-930. 10.4088/JCP.14m09128.
36. Fitzgerald P.B., Williams C.L., Corteling N., Filia S.L., Brewer K., Adams A., De Castella A.R.A., Rolfe T., Davey P., Kulkarni J. Subject and observer-rated quality of life in schizophrenia. Acta Psychiatr. Scand. 2001, 103:387-392.
37. Fleury M.-J., Grenier G., Bamvita J.-M., Tremblay J., Schmitz N., Caron J. Predictors of quality of life in a longitudinal study of users with severe mental disorders. Health Qual. Life Outcomes 2013, 11:92.
38. Galderisi S., Rossi A., Rocca P., Bertolino A., Mucci A., Bucci P., Rucci P., Gibertoni D., Aguglia E., Amore M., et al. The influence of illness-related variables, personal resources and context-related factors on real-life functioning of people with schizophrenia. World Psychiatry 2014, 13:275-287.
39. Granholm E., Ben-Zeev D., Link P.C. Social disinterest attitudes and group cognitive-behavioral social skills training for functional disability in schizophrenia. Schizophr. Bull. 2009, 35:874-883. 10.1093/schbul/sbp072.
40. Green M.F. What are the functional consequences of neurocognitive deficits in schizophrenia?. Am. J. Psychiatry 1996, 153:321-330. 10.1176/ajp.153.3.321.
41. Haro J.M., Novick D., Perrin E., Bertsch J., Knapp M. Symptomatic remission and patient quality of life in an observational study of schizophrenia: is there a relationship?. Psychiatry Res. 2014, 220:163-169. 10.1016/j.psychres.2014.07.034.
42. Heatherton T.F., Kozlowski L.T., Frecker R.C., Fagerström K.O. The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. Br. J. Addict. 1991, 86:1119-1127.
43. Hofer, Baumgartner S., Bodner T., Edlinger M., Hummer M., Kemmler G., Rettenbacher M.A., Fleischhacker W.W. Patient outcomes in schizophrenia II: the impact of cognition. Eur. Psychiatry 2005, 20:395-402.
44. Jaccard J., Wan C. LISREL Approaches to Interaction Effects in Multiple Regression 1996, Sage Publications, Thousand Oaks.
45. Jung H.Y., Hwang S.S.-H., Yi J.S., Kim Y., Kim Y.S. Clinician-rated functioning and patient-rated quality of life in schizophrenia: implications of their correspondence for psychopathology and side effects. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 2010, 34:225-230. 10.1016/j.pnpbp.2009.11.012.
46. Karow A., Wittmann L., Schöttle D., Schäfer I., Lambert M. The assessment of quality of life in clinical practice in patients with schizophrenia. Dialogues Clin. Neurosci. 2014, 16:185.
47. Kay S.R., Fiszbein A., Opfer L.A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr. Bull. 1987, 13:261.
48. Kirkpatrick B., Buchanan R.W. Anhedonia and the deficit syndrome of schizophrenia. Psychiatry Res. 1990, 31:25-30. 10.1016/0165-1781(90)90105-E.
49. Kurtz M.M., Tolman A. Neurocognition, insight into illness and subjective quality-of-life in schizophrenia: what is their relationship?. Schizophr. Res. 2011, 127:157-162. 10.1016/j.schres.2010.12.004.
50. Lançon C., Auquier P., Reine G., Toumi M., Addington D. Evaluation of depression in schizophrenia: psychometric properties of a French version of the Calgary Depression Scale. Psychiatry Res. 1999, 89:123-132. 10.1016/S0165-1781(99)00097-9.
51. Lasalvia A., Bonetto C., Malchiodi F., Salvi G., Parabiaghi A., Tansella M., Ruggeri M. Listening to patients' needs to improve their subjective quality of life. Psychol. Med. 2005, 1655-1665. 10.1017/S0033291705005611.
52. Lepage M., Bodnar M., Bowie C.R. Neurocognition: clinical and functional outcomes in schizophrenia. Can. J Psychiatr. Rev. Can. Psychiatr. 2014, 59:5-12.
53. Leucht S., Samara M., Heres S., Patel M.X., Woods S.W., Davis J.M. Dose Equivalents for Second-Generation 2014, The Minimum Effective Dose Method. Schizophr. Bull, Antipsychotics. 10.1093/schbul/sbu001.
54. Llorca P.-M., Lançon C., Lancrenon S., Bayle F.-J., Caci H., Rouillon F., Gorwood P. The "Functional Remission of General Schizophrenia" (FROGS) scale: development and validation of a new questionnaire. Schizophr. Res. 2009, 113:218-225. 10.1016/j.schres.2009.04.029.
55. Lysaker P.H., Dimaggio G. Metacognitive capacities for reflection in schizophrenia: implications for developing treatments. Schizophr. Bull. 2014, 40:487-491. 10.1093/schbul/sbu038.
56. Marchesi C., Affaticati A., Monici A., De Panfilis C., Ossola P., Ottoni R., Tonna M. Decrease of functioning in remitted and non-remitted patients 16 years after a first-episode schizophrenia. J. Nerv. Ment. Dis. 2015, 203:406-411.
57. Mauriño J., Mauriño J., Diez Impact of depressive symptoms on subjective well-being: the importance of patient-reported outcomes in schizophrenia. Patient Prefer. Adhere. 2011, 471. 10.2147/PPA.S24479.
58. Meesters P.D., Comijs H.C., de Haan L., Smit J.H., Eikelenboom P., Beekman A.T.F., Stek M.L. Subjective quality of life and its determinants in a catchment area based population of elderly schizophrenia patients. Schizophr. Res. 2013, 147:275-280. 10.1016/j.schres.2013.04.030.
59. Naber D., Kollack-Walker S., Chen J., Stauffer V.L., Kinon B.J., Case M., Ascher-Svanum H., Kapur S., Kane J.M. Predicting a "combined treatment outcome" in chronic schizophrenia: the role of demographics, symptomatology, functioning and subjective-well-being. Pharmacopsychiatry 2013, 46:114-119. 10.1055/s-0032-1331703.
60. Palmer B.W., Martin A.S., Depp C.A., Glorioso D.K., Jeste D.V. Wellness within illness: happiness in schizophrenia. Schizophr. Res. 2014, 159:151-156. 10.1016/j.schres.2014.07.027.
61. Perlick D.A., Rosenheck R.A., Kaczynski R., Bingham S., Collins J. Association of symptomatology and cognitive deficits to functional capacity in schizophrenia. Schizophr. Res. 2008, 99:192-199. 10.1016/j.schres.2007.08.009.
62. Rabinowitz J., Berardo C.G., Bugarski-Kirola D., Marder S. Association of prominent positive and prominent negative symptoms and functional health, well-being, healthcare-related quality of life and family burden: a CATIE analysis. Schizophr. Res. 2013, 150:339-342. 10.1016/j.schres.2013.07.014.
63. Sibitz I., Unger A., Woppmann A., Zidek T., Amering M. Stigma resistance in patients with schizophrenia. Schizophr. Bull. 2011, 37:316-323. 10.1093/schbul/sbp048.
64. Siris S.G. Depression in schizophrenia. Schizophrenia 1995, 128-145. S.R. Irsch, D.W. Einhorder (Eds.).
65. Szöke A., Trandafir A., Dupont M.-E., Meary A., Schurhoff F., Leboyer M. Longitudinal studies of cognition in schizophrenia: meta-analysis. Br. J. Psychiatry 2008, 192:248-257. 10.1192/bjp.bp.106.029009.
66. Szöke A., Méary A., Ferchiou A., Trandafir A., Leboyer M., Schürhoff F. Correlations between cognitive performances and psychotic or schizotypal dimensions. Eur. Psychiatry 2009, 24:244-250. 10.1016/j.eurpsy.2008.10.007.
67. Tabak N.T., Horan W.P., Green M.F. Mindfulness in schizophrenia: associations with self-reported motivation, emotion regulation, dysfunctional attitudes, and negative symptoms. Schizophr. Res. 2015, 168:537-542. 10.1016/j.schres.2015.07.030.
68. Tolman A.W., Kurtz M.M. Neurocognitive predictors of objective and subjective quality of life in individuals with schizophrenia: a meta-analytic investigation. Schizophr. Bull. 2012, 38:304-315. 10.1093/schbul/sbq077.
69. Ventura J., Tom S.R., Jetton C., Kern R.S. Memory functioning and negative symptoms as differential predictors of social problem solving skills in schizophrenia. Schizophr. Res. 2013, 143:307-311. 10.1016/j.schres.2012.10.043.
70. Xiang Y.-T., Weng Y.-Z., Leung C.-M., Tang W.-K., Ungvari G. Subjective quality of life in outpatients with schizophrenia in Hong Kong and Beijing: relationship to socio-demographic and clinical factors. Qual. Life Res. 2008, 17:27-36. 10.1007/s11136-007-9285-2.
71. Yanos P.T., Moos R. Determinants of functioning and well-being among individuals with schizophrenia: an integrated model. Clin. Psychol. Rev. 2007, 27:58-77. 10.1016/j.cpr.2005.12.008.